Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sleep quality after switching antiretroviral regimen from three to two drugs: DTG + lamivudine vs DTG + rilpivirine
TCTR20250218001Phase 3Recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dolutegravir, lamivudine, rilpivirine in human immunodeficiency virus infection (HIV), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Started Feb 2025; status: recruiting.
02
Drugs
dolutegravirlamivudinerilpivirine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on TCTR20250218001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250218001.